FDA expected to issue new warning on J&J COVID jab
The US FDA is expected to issue a new warning linking J&J's COVID-19 vaccine to Guillain-Barre syndrome.The US FDA is expected to issue a new warning linking J&J's COVID-19 vaccine to Guillain-Barre syndrome.